Fitzpatrick Alexander A insider trades

Fitzpatrick Alexander A has filed 10 Form 4s with the SEC that we hold, for ARS Pharmaceuticals, Inc. (SPRY) (Chief Legal Officer) and Evofem Biosciences, Inc. (EVFM) (General Counsel and Secretary). Across all of them we count 3 purchases worth $329.4K and 2 sales worth $1.5M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($33.5K). The largest single trade was a sale of 102,969 shares of ARS Pharmaceuticals, Inc. worth $1.5M, dated 2025-05-20. The first filing on our record is dated 2021-12-20 and the latest 2026-06-12.

ARS Pharmaceuticals, Inc. (SPRY)

Chief Legal Officer · 7 filings · 4 purchases and sales

Trade date	Code	Shares	Value as filed	Filed	Source
2023-09-28	P, purchase reported on Form 4	40,000	$144.8K	2023-10-02	SEC
2023-09-29	P, purchase reported on Form 4	46,258	$174.9K	2023-10-02	SEC
2025-05-20	S, sale reported on Form 4	102,969	$1.5M	2025-05-22	SEC
2026-06-12	S, sale reported on Form 4	3,355	$33.5K	2026-06-12	SEC

Evofem Biosciences, Inc. (EVFM)

General Counsel and Secretary · 3 filings · 1 purchase or sale

Trade date	Code	Shares	Value as filed	Filed	Source
2021-12-20	P, purchase reported on Form 4	25,000	$9.8K	2021-12-20	SEC

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1398595) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-28 · For informational purposes only, not investment advice.
Privacy · Terms